From: Efficacies of DHA–PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan
Outcome
DHA–PPQ N (%) (95% CI)
AS/SP N (%) (95% CI)
ETF
0 (0%) (0.0–6.5)
1 (1.5%) (0.0–8.3)
LCF
1 (1.8%) (0.0–9.7)
0 (0%) (0.0–5.5)
LPF
13 (20%) (11.1–31.8)
ACPR
54 (98.2%) (90.3–100)
51 (78.5%) (66.5–87.7)
Total
55
65